ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 141 out of 1006

$624K Total Retail Price of All Prescriptions

Rank: 140 out of 1006

297 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 7,248 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 353 285 1 2
LISINOPRIL 297 259 2 3
SIMVASTATIN 291 235 3 1
AMLODIPINE BESYLATE 258 227 4 4
ATORVASTATIN CALCIUM 246 206 5 5
HYDROCODONE-ACETAMINOPHEN 219 165 S3 6 25
FUROSEMIDE 217 196 7 6
METOPROLOL TARTRATE 182 159 8 7
SERTRALINE HCL 175 138 9 19
METFORMIN HCL 165 118 10 10
OMEPRAZOLE 153 112 11 9
WARFARIN SODIUM 151 137 12 8
DIOVAN 119 97 13 16
CRESTOR 118 84 14 18
DONEPEZIL HCL 108 98 15 17
METOPROLOL SUCCINATE 107 95 16 12
ATENOLOL 105 76 17 13
MIRTAZAPINE 104 84 18 26
ZOLPIDEM TARTRATE 102 66 19 14
TRAZODONE HCL 101 72 20 21
CYMBALTA 97 53 21 41
TRAMADOL HCL 96 76 22 35
PRAVASTATIN SODIUM 93 62 23 15
NAMENDA 86 86 24 34
RISPERIDONE 86 72 24 40
NEXIUM 81 72 26 28
ESCITALOPRAM OXALATE 74 74 27 27
TAMSULOSIN HCL 71 45 28 23
FENTANYL 70 49 S2 29 74
PROAIR HFA 70 50 29 64
PREDNISONE 68 59 31 33
QUETIAPINE FUMARATE 65 65 32 45
ADVAIR DISKUS 64 57 33 37
CARVEDILOL 62 54 34 36
LOSARTAN POTASSIUM 60 50 35 22
GABAPENTIN 60 36 35 20
DOXAZOSIN MESYLATE 60 60 35 87
IPRATROPIUM-ALBUTEROL 56 56 38 73
IBUPROFEN 53 43 39 114
AZITHROMYCIN 52 43 40 39
PHENYTOIN SODIUM EXTENDED 50 50 41 149
GLIMEPIRIDE 50 50 41 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.